VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
88,334
AK1,815
AL6,133
AR3,993
AS45
AZ14,539
CA64,759
CO12,159
CT8,719
DC1,747
DE1,868
FL41,499
FM3
GA16,132
GU92
HI2,477
IA4,739
ID2,763
IL21,496
IN23,655
KS4,844
KY8,414
LA5,328
MA15,281
MD13,105
ME3,277
MH8
MI20,143
MN12,873
MO10,275
MP30
MS3,073
MT2,392
NC17,450
ND1,440
NE3,023
NH3,124
NJ19,456
NM4,089
NV4,600
NY36,525
OH20,140
OK6,525
OR8,918
PA24,920
PR2,483
QM2
RI2,092
SC6,952
SD1,243
TN10,038
TX38,745
UT4,482
VA15,477
VI62
VT1,780
WA15,487
WI11,573
WV2,461
WY894
XB5
XL1
XV2

ID: 1349202
Sex: M
Age:
State: NC

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt feverish (though temp was 97.3) more sluggish amd more brain fog than before injection (like I was getting a cold or flu). Symptoms less apparent today; felt feverish (though temp was 97.3) more sluggish amd more brain fog than before injection (like I was getting a cold or flu). Symptoms less apparent today; felt feverish (though temp was 97.3) more sluggish amd more brain fog than before injection (like I was getting a cold or flu). Symptoms less apparent today; felt feverish (though temp was 97.3) more sluggish amd more brain fog than before injection (like I was getting a cold or flu). Symptoms less apparent today; felt feverish (though temp was 97.3) more sluggish amd more brain fog than before injection (like I was getting a cold or flu). Symptoms less apparent today; felt feverish (though temp was 97.3) more sluggish amd more brain fog than before injection (like I was getting a cold or flu). Symptoms less apparent today; This is a spontaneous report from a contactable consumer (patient). A 73-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration (at the age of 73-years-old), administered in Arm Left on 19Feb2021 13:30 (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunization. Medical history included Obstructive Sleep Apnea, ongoing sluggishness, ongoing brain fog, and COVID-19 ("If COVID prior vaccination: Yes"). Concomitant medications included armodafinil and doxepin hcl both taken for unspecified indications, start and stop dates were not reported. About 19 hours after injection (on 20Feb2021, 09:00 AM) felt feverish (though temp was 97.3), more sluggish and more "brain fog" than before injection ("like I was getting a cold or flu"). Symptoms less apparent today. No treatment received for the events. The patient underwent lab tests and procedures which included body temperature: 97.3 on 20Feb2021. The outcome of the events was Recovering/Resolving. Facility type vaccine was Public Health Clinic/Veterans Administration facility. No other vaccine in four weeks. Not COVID tested post vaccination. Information on the lot/batch number has been requested.

Other Meds: ARMODAFINIL; DOXEPIN HCL

Current Illness: Foggy feeling in head; Sluggishness

ID: 1349203
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt "achy"; This is a spontaneous report from a non-contactable consumer. A elderly male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as UNKNOWN, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the COVID-19 shot and he felt "achy" on unspecified date. It was unknown if treatment was received. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. It was unknown if the patient has been tested for COVID-19. The outcome of the event was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1349204
Sex: F
Age:
State: TN

Vax Date: 02/19/2021
Onset Date: 02/21/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sudden sensitivity; mild pain in jaws and lower lip area; mild pain in jaws and lower lip area; This is a spontaneous report from a contactable consumer (patient). A 72-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: EL9264, expiry date not reported), via an unspecified route of administration, administered in left arm on 19Feb2021 11:00 as first dose, single for covid-19 immunisation. Medical history included high blood pressure, low thyroid, and essential tremor. The patient had no known allergies. Concomitant medications included levothyroxine, hctz, trazodone, propranolol, and pravastatin, all taken for an unspecified indication, start and stop date were not reported. Patient was not pregnant at the time of vaccination and of the report. The patient had no other vaccine in four weeks. The patient had no covid prior vaccination. On 21Feb2021 16:30, the patient experienced sudden sensitivity and mild pain in jaws and lower lip area. No treatment received in response to the events reported. The patient was not tested for covid post vaccination. The patient was recovering from the events. Follow-up attempts are completed. No further information is expected.

Other Meds: LEVOTHYROXINE; HCTZ; TRAZODONE; PROPRANOLOL; PRAVASTATIN

Current Illness:

ID: 1349205
Sex: F
Age:
State: PA

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I had swelling on my forehead, between my eyebrows, down the bridge of my nose, and, both sides of the bridge of my nose.; This is a spontaneous report from a contactable nurse (patient). A 49-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in left arm on 12Jan2021 09:30 (Batch/Lot Number: EJ1686) (at the age of 49 years old) as 1st dose, single for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included penicillin allergy. No other vaccine in four weeks and no other medications in two weeks. The patient experienced swelling on forehead between eyebrows, down the bridge of my nose, and both sides of the bridge of my nose on 13Jan2021 06:30. No treatment for the event. No COVID prior vaccination. The patient underwent lab tests and procedures which included Nasal Swab: negative on 12Feb2021. The outcome of the event was recovered on unspecified date. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1349206
Sex: F
Age:
State: AZ

Vax Date: 02/15/2021
Onset Date: 02/01/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a non-raised red rash appeared on chest and stomach area...also partially on my back; As the rash faded, I have an itch everywhere the rash existed; This is a spontaneous report from a contactable consumer (patient). A 73-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9267) at the age of 73-years-old, via an unspecified route of administration in right arm on 15Feb2021 at 12:15 at 1st dose, single for COVID-19 immunization. Medical history included being asthmatic. She has no other chronic health conditions, no known allergies, and has no COVID prior to vaccination. Concomitant medications included ascorbic acid, betacarotene, biotin, calcium, chloride, chromium, copper, folic acid, iodine, iron, magnesium, manganese, molybdenum, nickel, nicotinic acid, pantothenic acid, phosphorus, potassium, pyridoxine hydrochloride, riboflavin, selenium, silicon, thiamine, vanadium, vitamin b12 nos, vitamin d nos, vitamin e nos, vitamin k nos, xantofyl, zinc (CENTRUM SILVER WOMEN 50+) and acetylsalicylic acid (ASPIRIN). There were no other vaccines in four weeks. The facility where the vaccine was administered was reported as other. On Feb2021 (also reported as 11Feb2021 at 08:30), a non-raised red rash appeared on her chest and stomach area and also partially on her back; as the rash faded, she had an itch everywhere the rash existed. No treatment was given in response to the events. The outcome of the events was recovering. Follow-up attempts are completed. No further information is expected.

Other Meds: CENTRUM SILVER WOMEN 50+; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1349207
Sex: F
Age:
State: AL

Vax Date: 02/09/2021
Onset Date: 02/10/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph node on left collar bone.; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 09Feb2021 17:05 (at 39 years old, not pregnant) (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation. The patient's medical history was not reported. Concomitant medication included losartan. On 10Feb2021 17:00, patient experienced Swollen lymph node on left collar bone. The outcome of the event was recovering. No treatment for the event. No covid prior vaccination. Not covid tested post vaccination. Follow-up attempts are completed. No further information is expected.

Other Meds: LOSARTAN

Current Illness:

ID: 1349208
Sex: F
Age:
State: FL

Vax Date: 02/15/2021
Onset Date: 02/16/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hint aches throughout body; very fatigued; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 15Feb2021 12:30 (at 76 years old) (Batch/Lot Number: EN6201) as 1st dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 16Feb2021, patient experienced Hint aches throughout body and very fatigued. No treatment for the events. The outcome of the events was not recovered. No other vaccine_in_four weeks. No covid_prior_vaccination. Not covid tested post vaccination.

Other Meds:

Current Illness:

ID: 1349209
Sex: F
Age:
State: MA

Vax Date: 02/16/2021
Onset Date: 02/17/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I had a terrible smell of burnt toast, the day following the shot, then the next day, none, then yesterday once again. No other side effects. Strangely my sister 500 miles from me also had smells of; This is a spontaneous report from a contactable consumer (patient herself). A female patient (age not provided) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number not provided), via an unknown route in the right arm, on 16Feb2021 15:30 at single dose for COVID-19 immunisation. The patient was not pregnant. Relevant medical history included atrial fibrillation and asthma. Past drug history included allergy to penicillin. Relevant concomitant medications included phenobarbital, clonidine, levothyroxine sodium (SYNTHROID), and pantoprazole. The patient verbally reported ''I had a terrible smell of burnt toast, the day following the shot, then the next day, none, then yesterday once again''. No other side effects. The patient stated also ''strangely my sister 500 miles from me also had smells of burning and gasoline''. Pre and Post vaccination COVID tests were not performed. The patient was not treated for the event. The patient was recovering from the event. No follow-up attempts are possible. Information about Batch/Lot number cannot be obtained.

Other Meds: PHENOBARBITAL; CLONIDINE; SYNTHROID; PANTOPRAZOLE

Current Illness:

ID: 1349210
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fast heart rate that lasted for 5 to 6 hours.; he felt a numb, tingling sensation down his arm, hands, palms, and fingers; he felt a numb, tingling sensation down his arm, hands, palms, and fingers; This is a spontaneous report from a non-contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Immediately after receiving the 1st dose of the Pfizer-BioNTech Covid-19 Vaccine, he experienced a fast heart rate that lasted for 5 to 6 hours. Then with the last 3 days, he felt a numb, tingling sensation down his arm, hands, palms, and fingers. He wants to know if this is a normal reaction to the vaccine, and if it is still safe for him to receive the 2nd dose of the vaccine. Outcome of the event fast heart rate was recovered; other events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1349211
Sex: F
Age:
State: WI

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy rash on back, stomach, wrists, ankles. Appeared about 36 hours post shot.; This is a spontaneous report from a contactable consumer A 43 -year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6200) on 19Feb2021 at 09:45 at single dose via an unspecified route of administration on right arm for COVID-19 immunization. Relevant medical history included migraines, depression, reynaud's syndrome, seasonal allergies, animal allergies and dust allergy. Concomitant medications included montelukast, escitalopram oxalate (LEXAPRO), trazodone, levocetirizine dihydrochloride (XYZAL). On 20Feb2021 at 17:00 the patient experienced itchy rash on back, stomach, wrists, ankles, appeared about 36 hours post shot. At the time of the reporting the patient had not yet recovered from the event Follow-up attempts are completed. No further information is expected.

Other Meds: MONTELUKAST; LEXAPRO; TRAZODONE; XYZAL

Current Illness:

ID: 1349212
Sex: F
Age:
State: PA

Vax Date: 02/11/2021
Onset Date: 02/01/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tired; cold; head was in a fog; Staggering; Diarrhea; ears were ringing; arm was sore; body ache; neck was painful; back of head pain; This is a spontaneous report from a contactable consumer (Patient). A 79-year old female consumer reported that she received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number EL0140, Expiration Date Mar2021) into the left arm on 11Feb2021 at 4:00pm (at the age of 79-years-old) at single dose for COVID-19 immunization. Concomitant drugs included ciclosporin (RESTASIS) twice daily both eyes taken for dry eye; bimatoprost (LUMIGAN) one daily both eyes taken for glaucoma for 5-6 years, vitamin B complex 1 daily taken as supplement for 15-20 years; colecalciferol (D3) 2 daily during the winter and 1 daily in the summer taken as supplement for 3-4 years. She use to get a lot of sore throats. Her doctor suggested she take vitamins. Some that she took didn't help. On 11Feb2021 the patient experienced arm was sore not recovered, body ache recovered on 13Feb2021 and on 12Feb2021 she experienced tired recovered on 13Feb2021, cold recovered on 12Feb2021, head was in a fog not recovered, staggering recovered on 13Feb2021, ears were ringing recovered on 13Feb2021, Diarrhea recovered on 12Feb2021. Further reported the back of her head and neck was painful that was gone by 13Feb2021. Her arm was sore if she lays on it she can feel it. Unable to answer outcome of event for being tired,if she sits long enough she falls asleep. Her head still feels tender. She is no longer staggering. She feels comfortable going up and down stairs. The next dose is scheduled for 04Mar2021. She is considering not taking the second dose.

Other Meds: RESTASIS; LUMIGAN; VITAMIN B COMPLEX; D3

Current Illness:

ID: 1349213
Sex: F
Age:
State:

Vax Date: 02/01/2021
Onset Date: 02/18/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a little bit of a Headache; This is a spontaneous report from a contactable consumer, based on information received by Pfizer from Eisai (manufacturer control number: EC-2021-088274). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in Feb2021 (Batch/Lot number was not reported) as single dose (unknown if first or second dose) for COVID-19 immunisation and lenvatinib mesilate (LENVIMA) via an unspecified route of administration from 15Feb2021 at 20 mg daily for endometrial uterine cancer. Relevant medical history included ongoing malignant hypertension (blood pressure still runs high), 2 brain aneurysms, left thyroid lobe enlarged a number of years and endometrial uterine cancer. Concomitant medications were not reported. On 18Feb2021, the patient experienced a little bit of a headache. The patient stated she got a "COVID vaccine" last week (before starting LENVIMA) and patient's Doctor told her the "headache" cold be from the vaccine too. Cause unknown but occurred while on LENVIMA. The patient reported that her blood pressure was 149/82 on 18Feb2021 and it was 132/66 on 17Feb2021, which was low for her. The patient was instructed by her Doctor to notify her Doctor if blood pressure was ever "160/100, or higher." At the time of the report, the action taken with lenvatinib mesilate and the outcome of the event were unknown. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds: LENVIMA

Current Illness: Malignant hypertension (Blood Pressure still runs high)

ID: 1349214
Sex: F
Age:
State: NY

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: After the 1st shot, the muscle under my left thumb started to hurt; This is a spontaneous report from a non-contactable consumer. A 59-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL3247) via an unspecified route of administration in left arm on 12Feb2021 03:00PM at single dose for COVID-19 immunisation. Relevant medical history was not reported, the patient did not receive any vaccine in four weeks and had allergy to codeine. The patient did not have COVID prior to vaccination and was not tested for COVID post vaccination. Concomitant medications were not reported. On 23Jan2021, after the first shot, the muscle under her left thumb started to hurt. The event was not treated, was non-serious and not resolved. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021218557 same patient/reporter, different AE/second dose

Other Meds:

Current Illness:

ID: 1349215
Sex: F
Age:
State:

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore Arm; This is a spontaneous report from a non-contactable Other HCP (patient herself). This 26-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EN5318), via an unknown route in the left arm, on 26Jan2021 (at the age of 26-year-old) at single dose for COVID-19 immunisation. No other vaccine was received in four weeks. Relevant medical history included COVID-19 (before vaccine). No relevant concomitant medications were provided. On 26Jan2021, the patient had sore arm. The event was reported as non-serious. No treatment was given for the event. Pre and Post vaccination COVID tests were not performed. The patient recovered from the event on unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1349216
Sex: F
Age:
State:

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I experienced mild joint/muscle aches the day after receiving the 2nd shot. The side effect lasted for only 1 day.; I experienced mild joint/muscle aches the day after receiving the 2nd shot. The side effect lasted for only 1 day.; This is a spontaneous report from a non-contactable consumer. A 57-years-old, non-pregnant, female patient received the second dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine via an unspecified route of administration on 19Feb2021 (Batch/Lot Number: EL3247) as for COVID-19 immunization. The patient had no relevant medical history. The patient's concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID after vaccination. The patient reported that, the day after receiving the 2nd shot, on 20Feb2021 08:00, she experienced mild joint/muscle aches. The side effect lasted for only 1 day. The events recovered on an unspecified date in Feb2021 without any treatment. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1349217
Sex: F
Age:
State: GA

Vax Date: 02/20/2021
Onset Date: 02/21/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 24 hrs after vaccination I began to have a speckled rash; itchy skin on chest, back,arms; This is a spontaneous report from a Non-contactable consumer. A 75 year old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3302) on 20Feb2021 at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. On 21Feb2021 24 hours after vaccination patient began to have a speckled rash and itchy skin on chest, back, arms. No treatment received. At the time of the reporting the patient had not yet recovered from the events. No follow-up attempts are possible. No further information is expected

Other Meds:

Current Illness:

ID: 1349218
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: After the second dose, her platelet count dropped.; This is a spontaneous report from a contactable Nurse reporting for herself. A female patient of an unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number unknown) via an unspecified route of administration on an unspecified date, at single dose for COVID-19 immunisation. Relevant medical history included idiopathic thrombocytopenic purpura (ITP). Concomitant medications were not reported. After the second dose, her platelet count dropped. Because of that, she was taking prednisone. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1349219
Sex: F
Age:
State: IN

Vax Date: 02/20/2021
Onset Date: 02/22/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph nodes under right arm; This is a spontaneous report from a contactable Healthcare Professional reporting for herself. A 53-years-old, non-pregnant, female patient received the second dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine in Hospital, via an unspecified route of administration, administered in right arm on 20Feb2021 09:30 (Batch/Lot Number: EN6200) as single dose for COVID-19 immunization. The patient's medical history was not reported. Historical vaccine included the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine in right arm on 25Jan2021 06:00 PM (Batch/Lot Number: EL8982) as single dose for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior vaccination and was not tested for COVID post vaccination. Concomitant medication included omeprazole taken for an unspecified indication, start and stop date were not reported. The patient experienced swollen lymph nodes under right arm on 22Feb2021 06:00. No treatment was administered for the event. The event had not resolved yet at the time of the report. No follow-up attempts are possible. No further information is expected.

Other Meds: OMEPRAZOLE

Current Illness:

ID: 1349220
Sex: F
Age:
State: NJ

Vax Date: 02/16/2021
Onset Date: 02/17/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: About 20 hrs after second dose, I experienced low grade fever (100.4 degree f).; chills; fogginess; This is a spontaneous report from a contactable consumer. A 30-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: En6201) on 16Feb2021 at 16:00 at single dose via an unspecified route of administration on left arm for COVID-19 immunization. The patient didn't have medical history. Concomitant drug included metformin and melatonin. The patient received first dose of BNT162B2 on 22Jan2021 at 04:00 pm on left arm. On 17Feb2021 at 13:00 about 20 hours after second dose, patient experienced low grade fever (100.4 degree f). The patient recovered from the events on an unspecified date. No follow-up attempts are possible. No further information is expected.

Other Meds: METFORMIN; MELATONIN

Current Illness:

ID: 1349221
Sex: F
Age:
State: IL

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: if she pressed on the vaccine injection site, the vaccine injection site was slightly tender; This is a spontaneous report from a contactable consumer (patient herself). This 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number EL3247 with Expiration Date 31May2021), via intramuscular in the left upper arm, on 27Jan2021 15:00 (at the age of 74-year-old) at single dose for COVID-19 immunisation. No other vaccine was received in four weeks. No relevant medical history was provided. Relevant concomitant medications included levothyroxine. On 27Jan2021, the patient stated if she pressed on the vaccine injection site, the vaccine injection site was slightly tender. The patient had recovered from the event on 28Jan2021. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021183324 same patient, same product (second dose), different event

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1349222
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; joint pain; headache; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation. Medical history included gout and osteoarthritis. Concomitant medications included indomethacin [indometacin] and colchicine. The patient got the first dose of the covid vaccine and has developed fever, joint pain and headache. The patient has gout and osteoarthritis and she take indomethacin and colchicine however she has not taking those medications lately and she mentioned that she usually gets joint pain from her osteoarthritis. She went to her primary doctor and to the hospital and no one wanted to attend her since she has fever. She would like to know which medication she can take for her fever. The outcome of the events was unknown. No follow-up attempts are possible, information about lot number cannot be obtained. No further information is expected.

Other Meds: INDOMETHACIN [INDOMETACIN]; COLCHICINE

Current Illness:

ID: 1349223
Sex: F
Age:
State: MA

Vax Date: 02/06/2021
Onset Date: 02/08/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills but no fever; Headaches for one and a half weeks; Dizziness; This is a spontaneous report from a contactable consumer reported for herself. A 94-year-old female consumer reported that received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number unknown), on 06Feb2021 12:00 AM (at the age of 94-years-old) at single dose for COVID-19 immunization. medical history included Allergies to Penicillin. Concomitant drugs were unknown. On 08Feb2021 the patient had chills but no fever. Headaches for one and a half weeks and Dizziness. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1349224
Sex: M
Age:
State: KY

Vax Date: 01/10/2021
Onset Date: 01/01/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: symptoms of nausea and lethargy; symptoms of nausea and lethargy; This is a spontaneous report from a contactable consumer reporting on behalf of the patient. A 75 (unspecified unit) old male patient (husband) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 10Jan2021 (Batch/Lot number was not reported) as 2nd dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient also received first dose of BNT162B2 on unspecified date (unknown lot number and expiration) for COVID-19 immunization. It was reported that the patient experienced symptoms of nausea and lethargy a week later in Jan2021. Outcome of the events was unknown. The events were assessed as non-serious. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1349225
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: just a sore arm; This is a spontaneous report from a Pfizer sponsored program from a non-contactable consumer reported for a female patient (friend) A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. he patient medical history and concomitant medications were not reported. The patient experienced just a sore arm at the injection site on an unspecified date with outcome of unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1349226
Sex: F
Age:
State: NY

Vax Date: 02/14/2021
Onset Date: 02/14/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 14Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient reported that with the past flu shots that she has received she has experienced fever and body aches. The patient experienced a sore arm for around 5 hours a several hours after receiving the vaccine on 14Feb2021 with outcome of unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1349227
Sex: F
Age:
State: WI

Vax Date: 02/19/2021
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I had a fever; weird strange dream; This is a spontaneous report from a contactable consumer (patient). A 82-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 19Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced fever with outcome of unknown , weird strange dream with outcome of unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1349228
Sex: M
Age:
State:

Vax Date: 02/21/2021
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: experienced pain in his shoulder; This is a spontaneous report from a contactable consumer (patient himself). A male patient of unspecified age (reported as 'Age:68; Unit: Unknown') received received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Feb2021 (Batch/Lot number was not reported) as 2nd dose, single for COVID-19 immunisation. Medical history included injury unrelated to the COVID-19 vaccine. The patient's concomitant medications were not reported. The patient stated he only experienced pain in his shoulder on an unspecified date. He had several injuries unrelated to the COVID-19 vaccine and wanted to know how long he had to wait to take a pain pill for his other injuries. Outcome of the event was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1349229
Sex: M
Age:
State:

Vax Date: 01/19/2021
Onset Date: 01/01/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: gradually being short of breath/ huffing and puffing; This is a spontaneous report from a non-contactable consumer (patient's wife). A 72-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. About 8 days after the first dose in Jan2021, the patient started noticing gradually being short of breath. He would walk for 50 yards and he would be huffing and puffing which is unusual because he can walk a lot. It gradually got worse. Outcome of the event was not recovered. Patient received his second dose on 10Feb2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1349230
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: It's just a discomfort; pain; This is a spontaneous report from a Pfizer-sponsored program COVAX US Support. A contactable consumer (patient herself) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient stated she was due to receive the second dose on 25Feb2021. She wanted to go to the orthopedic doctor to discuss an underlying medical condition. She wanted to know in case she was to receive cortisone shot, if it would it impact the efficacy of the vaccine. She stated "I am going hold off going to the doctor. It's doesn't bother me as much. It's just a discomfort. I am not in excruciating pain. I will wait and take Tylenol for the pain. However I won't take Tylenol right before my shot." The events occurred on an unspecified date with outcome of unknown. Follow-up attempts are completed. No further information is expected. Information about the batch/lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1349231
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Affected my Menstrual cycle. Got my period 2 weeks early.; This is a spontaneous report from a non-contactable other healthcare professional. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EL9265) via intramuscular, administered in right arm, on an unspecified date, as 2nd dose, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient has no known allergies. Historical vaccine included 1st dose of COVID-19 vaccine on unspecified date. The patient had no COVID prior vaccination and she was not tested for COVID post vaccination. The patient was not pregnant at the time of report. It was reported that the patient's menstrual cycle was affected on unspecified date and got her period 2 weeks early. No follow-up attempts are possible. No further information is expected

Other Meds:

Current Illness:

ID: 1349232
Sex: M
Age:
State:

Vax Date: 01/23/2021
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: involuntary muscle twitching on the arm right after the 1st dose taken on 23Jan2021; This is a spontaneous report received from a contactable consumer (patient). A male patient with age reported as 39 (unit unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), via unspecified route of administration in right arm on 23Jan2021 as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient mentioned that he received both doses of the Pfizer COVID vaccine. He experienced muscle twitching on the arm right after the 1st dose taken on 23Jan2021. He was asking if that was reported as a common side effect. He was also asking if Amyotrophic Lateral Sclerosis (ALS) was a contraindication to vaccination or if it was reported to be a comorbidity in the clinical trials. The outcome of the event was unknown. Information about lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1349233
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: after his dose he had a warm/burning sensation at the injection site; after his dose he had a warm/burning sensation at the injection site; This is a spontaneous report from a contactable consumer who reported on behalf of her husband. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration in his left arm on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. About 1 to 2 hours after his dose, he had a warm/burning sensation at the injection site, which resolved on an unspecified date. Reporter was curious as to why the nurse told patient the vaccine goes in his left arm, even though he was left handed. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1349234
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/11/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I developed a dry cough 3 days after getting the 2nd dose of Pfizer vaccine; This is a spontaneous report from a contactable consumer(patient). A 59-year-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration, in left arm on 08Jan2021 (at 59 years) at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had previous known allergy to flurbuprophen. Previously on 18Dec2020 at 14:45 (at 59 years) the patient took the first dose of the vaccine in left arm for covid-19 immunization. On 11Jan2021, 3 days after getting the 2nd dose of the vaccine, the patient developed a dry cough.The event required doctor or other healthcare professional office/clinic visit. Patient was tested negative for Covid (via Nasal Swab) on 05Feb2021; X-ray in Feb2021 was negative for pneumonia. Patient had a course of antibiotics, a corticosteroid and cough medicines. As of 23Feb2021 patient still had the cough. The final outcome of the event was not recovered. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1349235
Sex: F
Age:
State:

Vax Date: 02/22/2021
Onset Date: 02/23/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: eyes were blood red; This is a spontaneous report received from a contactable consumer (patient). A female patient with age reported as 77 (unit unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), on 22Feb2021 as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that patient received the first dose of the vaccine the day before the present report (22Feb2021) in the afternoon. The day of this report (23Feb2021), she noticed her eyes were blood red. She also asked if there were any reports of eyes being blood red. The outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1349236
Sex: F
Age:
State:

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tired and not feeling like herself; tired and not feeling like herself; This is a spontaneous report from a Non-contactable consumer. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown) on 23Feb2021 at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. On 23Feb2021 the patient experienced tired and not feeling like herself. At the time of the reporting events outcome was unknown. No follow-up attempts are Possible. Information on lot/batch cannot be obtained.

Other Meds:

Current Illness:

ID: 1349237
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I started feeling some excruciating pain in my neck; it is a little bit swollen; This is a spontaneous report from a contactable consumer (patient). A 77-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated that had first shot on the 16th of the month and was supposed to go back for second shot on the 16th (as reported), it was supposed to go this afternoon. Today (as reported) the patient started feeling some excruciating pain in neck, she had been taking things (as reported) and now it's changed a little and it's the back of my neck. The patient done heat and ice because it was a little bit swollen, coming from the vaccine 3 weeks after getting vaccine. Outcome of the event neck pain was recovering while outcome of the event neck swelling was unknown. Lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.

Other Meds:

Current Illness:

ID: 1349238
Sex: F
Age:
State: MA

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: allergic reaction; face was flushed.warm; face was flushed,warm; swelling; ears were red and hot; ears were red and hot; felt a bit off; This is a spontaneous report from a non-contactable Consumer. A 72-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration (at the age of 72) on 20Feb2021 10:45 as single dose for covid-19 immunisation. Medical history included Follicular Non-Hodgins lymphoma, sleep apnoea syndrome, coronary artery disease, drug hypersensitivity to sulfur and penicillin, iodine contrast dye allergy. The patient's concomitant medications were not reported. No other vaccine was received in four weeks. No covid prior vaccination. No covid tested post vaccination. The patient experienced allergic reaction on 20Feb2021 10:45, face was flushed.warm on 20Feb2021 10:45, swelling on 20Feb2021 10:45, ears were red and hot on 20Feb2021 10:45, felt a bit off on 20Feb2021 10:45. No treatment received. The events outcome was recovered ('by 11PM most of this resolved' as reported). No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1349239
Sex: M
Age:
State:

Vax Date: 02/22/2021
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a little soreness to his arm where he had the injection; This is a spontaneous report from a contactable consumer (patient himself). A male patient of an unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 22Feb2021 at single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. The patient had his first shot and was scheduled for his second dose on 15Mar2021. The patient experienced a little soreness to his arm where he had the injection. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1349240
Sex: F
Age:
State: OK

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; fever; aches; sleepiness; brain fog; flu-like symptoms (Just like Covid that I had); This is a spontaneous report from a contactable consumer (patient). A 62-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right (at the age of 62) on 22Feb2021 10:00 (Lot Number: EL9267) as single dose for covid-19 immunisation. The patient medical history included covid prior to vaccination. No known allergies. Concomitant medications included imipramine, propranolol. The patient experienced headache on 22Feb2021 14:00, fever on 22Feb2021 14:00, aches on 22Feb2021 14:00, sleepiness on 22Feb2021 14:00, brain fog on 22Feb2021 14:00, flu-like symptoms on 22Feb2021 14:00. No treatment received. No covid tested post vaccination. The events outcome was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: IMIPRAMINE; PROPANOLOL [PROPRANOLOL]

Current Illness:

ID: 1349241
Sex: F
Age:
State:

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: flu like symptoms; Fever; Chills; sweating profusely; Ache; This is a spontaneous report from a contactable Healthcare Professional. A healthy female patient of an unspecified age received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine via an unspecified route of administration, in left arm on 02Feb2021 at 12:30PM (Batch/Lot Number: EL9261; Expiration Date: Jul2021) as single dose for COVID-19 immunization. Medical history included anaemia: she has been anemic for at least 3 years, she said she knows anemia is considered to be a blood disorder, but she feels her anemia is very common; she said her anemia is related to a fibroid that causes heavy menstrual bleeding. The patient reported that her husband was COVID-19 positive in late Oct2020. She initially tested negative, but felt ill while quarantined with her husband and was never retested to see if she was positive. She believes she was. She said she and her husband quarantined together at home for 14 days, and their quarantine ended a week before Thanksgiving (2020.) She said she believes she got the COVID-19 Virus a week or two after her husband tested positive for the COVID-19 Virus because she had symptoms during that time. She said since she was already quarantining at home, she did not go and have a second COVID-19 Virus test. She reported that when she had symptoms while she was quarantining in late Oct2020 and Nov2020, she drank ginger tea, saying ginger tea has anti-inflammatory properties. There were no concomitant medications. On 02Feb2021 at around 8:00PM-9:00PM the patient experienced flu like symptoms, fever, chills, sweating profusely and ache, which lasted for the first 24 hours and then resolved, but didn't lose her sense of taste or smell. She clarified she felt like she had a fever, but never checked her temperature because her thermometer was not working at the time. She said she thought she had a fever because she had chills, was sweating profusely, and was achy the night of 02Feb2021. She took 2 Ibuprofen 200 mg tablets (400 mg total), Lot Number: 9KE2695A, Expiration Date: Jul2021, the next day, on 03Feb2021. Moreover, she said that, when she didn't feel good after having her first COVID-19 Vaccine dose, she had a cup of ginger tea later on in the day of 03Feb2021 (approximately 4:00 PM). She said she makes the ginger tea herself with fresh ginger and lemon in warm water. She is scheduled to receive dose two of the vaccine on 23Feb2021. She has heard that the second dose of the vaccine has made people ill and is thinking the antibodies that she has from having COVID-19 in Oct2020 caused her to have the flu like symptoms she experienced after the first dose of the vaccine. She said she is nervous about getting her second COVID-19 Vaccine shot because she has heard people are sick for 3-4 days after getting the second COVID-19 Vaccine shot. She said her husband already had tested for the COVID-19 Virus antibodies. She asked if she already had the COVID-19 Virus antibodies, would the first COVID-19 Vaccine shot be doing what the second COVID-19 Vaccine shot was doing for everybody else. The patient clarified she was never tested for the COVID-19 Virus antibodies. The patient underwent lab tests and procedures which included complete full blood count on and unknown date and SARS-CoV-2 antibody test: negative in Oct2020. She explained she gets her iron levels checked 3 times a year and has a CBC done to monitor her anemia. The reported events resolved on 03Feb2021. As of 21Jan2020, a search of the published medical literature identified limited information regarding the use of Pfizer-BioNTech COVID-19 Vaccine (also known as BNT162b2) in patients with COVID-19 or tested positive for COVID 19. A summary of relevant information follows. Data from clinical trials indicate that mRNA COVID-19 vaccines can safely be given to persons with evidence of a prior SARS-CoV-2 infection. Vaccination should be offered to persons regardless of history of prior symptomatic or asymptomatic SARS-CoV-2 infection. Viral testing to assess for acute SARS-CoV-2 infection or serologic testing to assess for prior infection for the purposes of vaccine decision-making is not recommended. Vaccination of persons with known current SARS-CoV-2 infection should be deferred until the person has recovered from the acute illness (if the person had symptoms) and criteria have been met for them to discontinue isolation. This recommendation applies to persons who develop SARS-CoV-2 infection before receiving any vaccine doses as well as those who develop SARS-CoV-2 infection after the first dose but before receipt of the second dose. While there is no recommended minimum interval between infection and vaccination, current evidence suggests that the risk of SARS-CoV-2 reinfection is low in the months after initial infection but may increase with time due to waning immunity. Thus, while vaccine supply remains limited, persons with recent documented acute SARS-CoV-2 infection may choose to temporarily delay vaccination, if desired, recognizing that the risk of reinfection, and therefore the need for vaccination, may increase with time following initial infection. For vaccinated persons who subsequently develop COVID-19, prior receipt of an mRNA COVID-19 vaccine should not affect treatment decisions (including use of monoclonal antibodies, convalescent plasma, antiviral treatment, or corticosteroid administration) or timing of such treatments. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1349242
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; This is a spontaneous report from a contactable consumer (Patient). A 65-year old male consumer patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown) on an unspecified date at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. On an unspecified headache the patient experienced. At the time of the reporting outcome of event was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1349243
Sex: F
Age:
State:

Vax Date: 02/16/2021
Onset Date: 02/01/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; fever; This is a spontaneous report from a non-contactable consumer (patient) by a a Pfizer sponsored program COVAX US Support. A 79-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 16Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced chills and fever following first dose in Feb2021. The patient underwent lab tests and procedures which included sars-cov-2 test positive in Dec2020. Outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1349244
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Caller reports that her mom also has laryngitis, but no fever; This is a spontaneous report from a contactable consumer (daughter). A 82-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced caller reports that her mom also has laryngitis, but no fever on an unspecified date. The outcome was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1349245
Sex: F
Age:
State: PA

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: running a temperature; headache; arm was swollen; arm was swollen; arm was swollen and very sore; Not feeling well; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the age of 73 years old, administered in arm left on 22Feb2021 as single dose for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient stated she hasn't taken anything before or after the vaccine and was not on any medication. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN9581), via an unspecified route of administration at the age of 73 years old, on 18Jan2021 as single dose for covid-19 immunisation and had arm was swollen. The patient received the second dose on 22Feb2021 and she was not feeling well left on 22Feb2021. Her arm was swollen and very sore, she was running a temperature and each time that she took it is going up, she also had a headache. The patient said that her arm was swollen after the first dose too. She did not know what to do with herself. She said that she wanted directions on what she should do, is there anything that she can take to bring her temperature down. The patient said that her arm started getting sore last evening, on 22Feb2021. She massaged it and iced it. She had swelling this morning on 23Feb2021. This happened the last time, but she did not run a fever last time. The patient said that her temperature was 98.5, then 98.7, then 100.2. She woke up on 23Feb2021 with the temperature and the headache. She stated that the writing after the 6 in the lot number was not clear and was scribbled on the card. The patient provided the second dose Lot as EN6 and the rest was unclear. The outcome of the event not feeling well was not recovered, of the other events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1349246
Sex: F
Age:
State:

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: malaise; chills; discomfort under armpit; laryngitis; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date in Feb2021 (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was tested positive for COVID on 18Dec2020. The outcome of events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1349247
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; nausea; get sick after it; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced fever on an unspecified date with outcome of unknown, nausea on an unspecified date with outcome of unknown , get sick after it (illness) on an unspecified date with outcome of unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1349248
Sex: F
Age:
State: CA

Vax Date: 02/14/2021
Onset Date: 02/14/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Queasiness; headache; dizziness; Queasiness, headache, dizziness. Which keeps progressing; This is a spontaneous report from a contactable consumer, the patient. A 67-years-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, lot number: EN6200) via an unspecified route of administration in left arm on 14Feb2021 at 12:00 PM as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient had no known allergies. Patient did not take any other medications in two weeks. Patient did not receive any other vaccine within 4 weeks. Patient neither diagnosed with COVID-19 prior to vaccination nor been tested for COVID-19 after the vaccination. On 14Feb2021 at 13:15, the patient experienced queasiness, headache and dizziness which kept progressing. Patient did not receive any treatment. Outcome of the events was not recovered. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1349249
Sex: F
Age:
State: MD

Vax Date: 02/23/2021
Onset Date: 02/24/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Symptoms of full-body chills; swelling of lymph nodes; headache; nausea; This is a spontaneous report from a contactable consumer (patient). A 56-year-old non-pregnant female patient received second dose of BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number not reported) (non-pregnant at the time of vaccination) via intramuscular route of administration on 23Feb2021 15:15 in arm left as single dose for COVID-19 immunisation. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included hypertension. Concomitant medication included escitalopram, alprazolam, amlodipine taken for an unspecified indication. Historical vaccine included first dose of BNT162B2 on 03Feb2021 in the right arm at single dose for COVID-19 immunisation. No COVID prior vaccination. The patient was not tested for COVID post vaccination. On 24Feb2021 04:00, the patient experienced full-body chills, swelling of lymph nodes, headache and nausea. Outcome of the events were not recovered. Follow-up attempts are completed. No further information was expected.

Other Meds: ESCITALOPRAM; ALPRAZOLAM; AMLODIPINE

Current Illness:

ID: 1349250
Sex: F
Age:
State: DE

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; This is a spontaneous report received from a contactable consumer (patient's sister). A 67-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration in arm right, on 19Feb2021 at 67 years, as single dose, for COVID-19 immunisation. Patient was not pregnant and was not pregnant at time of vaccination. The patient's medical history and concomitant medications were not reported. The patient has not been diagnosed with COVID-19 prior to vaccination. Patient did not have known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient experienced sore arm (non-serious) on 19Feb2021 with outcome of recovered. No therapeutic measures were taken. Patient has not been tested for COVID-19 since the vaccination. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1349251
Sex: F
Age:
State: MO

Vax Date: 01/29/2021
Onset Date: 02/03/2021
Rec V Date: 05/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I have developed deep red, almost purple hives on both sides of my buttock.; This is a spontaneous report from a contactable consumer (patient). A 67-year-old non-pregnant female patient (67 years age at vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9269, Expiration date not reported), via an unspecified route of administration, in right arm on 29Jan2021 at 14:45 as single dose for covid-19 immunisation. It was reported that the patient received her second dose of BNT162B2 (Lot/Batch Number: EN6198) on 23Feb2021 at 14:45 in right arm. The patient's medical history included multiple sclerosis from an unknown date and unknown if ongoing. She was not diagnosed with covid-19 prior to vaccination nor was diagnosed post vaccination. She was unaware of any known allergies. Her concomitant medication(s) included dimethyl fumarate (TECFIDERA), tramadol hydrochloride (TRAMADOL), atorvastatin (ATORVASTATIN), losartan (LOSARTAN) and methylphenidate hydrochloride (RITALIN) taken for unspecified indication two weeks at the time of report. The patient developed deep red, almost purple hives on both sides of her buttock on 03Feb2021.She went to an urgent care and as treatment medication, she was put on Benadryl and Prednisone pack (unspecified formulation and dosage regimen) for 6 days. The outcome of the event was reported as not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds: TECFIDERA; TRAM DOL; ATORVASTATIN; LOSARTAN; RITALIN

Current Illness:

Total 2021 VAERS Injuries: 679,999

Page last modified: 03 October 2021 5:28pm